SOLD OUT: California Institute of Integral Studies presents a screening of Fantastic Fungi, a documentary sharing the benevolent wisdom of mushrooms and a discussion about psychedelics at end of life.
Is it the best or worst of times? This startlingly insightful, stunningly beautiful film will forever change your perspective. Fantastic Fungi argues that the benevolent wisdom of the world lies within mycelia we know as mushrooms. The documentary follows mycologist, Paul Stamets, who has discovered ways of using fungi to clean up toxic spills and who (convincingly) asserts that this oldest biological kingdom embodies a conscious intelligence that can heal our threatened world.
After viewing Fantastic Fungi, a panel with Dr. Ira Byock, Dr. Janis Phelps of the California Institute of Integral Studies, and Dr. Anthony Bossis of NYU’s School of Medicine, will explore the potential for mushrooms to heal our befouled environment and human suffering of persistent depression, anxiety, addiction, and spiritual distress -- especially when facing life’s end. It’s a tall order and promises to be a lively discussion!
Ira Byock, M.D is a palliative care physician, author, and public advocate for MUCH better health care. He is founder & chief medical officer of the Institute for Human Caring. He’s also an Active Emeritus Professor of the Geisel School of Medicine at Dartmouth. His books include Dying Well and The Best Care Possible.
Janis Phelps, Ph.D. is founder of the California Institute of Integral Studies Center for Psychedelic Therapies and Research, the first academically accredited training program in the field. Dr. Phelps is a board member of the Heffter Research Institute and her recent publications focus on clinical competencies and training models in psychedelic-assisted therapies.
Anthony P. Bossis, Ph.D. is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine and a training supervisor of psychotherapy at NYU-Bellevue Hospital Center. Since 2008, Dr. Bossis has been conducting FDA-approved clinical research with the psychedelic compound psilocybin including a study showing a significant reduction in psychological and existential distress in persons with cancer or at the end of life.